Elevation Oncology Correlations
| ELEV Stock | USD 0.30 0.02 7.14% |
The current 90-days correlation between Elevation Oncology and Ocean Biomedical is 0.02 (i.e., Significant diversification). The correlation of Elevation Oncology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Elevation Oncology Correlation With Market
Average diversification
The correlation between Elevation Oncology and DJI is 0.16 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Elevation Oncology and DJI in the same portfolio, assuming nothing else is changed.
Elevation |
Moving together with Elevation Stock
| 0.7 | SCLX | Scilex Holding | PairCorr |
| 0.69 | ASMB | Assembly Biosciences Earnings Call This Week | PairCorr |
| 0.71 | CMND | Clearmind Medicine Common | PairCorr |
| 0.62 | HD | Home Depot | PairCorr |
Moving against Elevation Stock
| 0.64 | PG | Procter Gamble | PairCorr |
| 0.56 | LUCD | Lucid Diagnostics | PairCorr |
| 0.49 | WM | Waste Management | PairCorr |
| 0.68 | JNJ | Johnson Johnson | PairCorr |
| 0.67 | T | ATT Inc Earnings Call Tomorrow | PairCorr |
| 0.42 | XOM | Exxon Mobil Corp | PairCorr |
| 0.36 | INTC | Intel | PairCorr |
| 0.34 | MMM | 3M Company | PairCorr |
| 0.34 | IBM | International Business | PairCorr |
| 0.33 | CVX | Chevron Corp | PairCorr |
Related Correlations Analysis
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | CWBR | ||
| 0.0 | 0.0 | 0.9 | 0.95 | 0.95 | OCEA | ||
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | AVRO | ||
| 0.0 | 0.9 | 0.0 | 0.82 | 0.9 | ZURA | ||
| 0.0 | 0.95 | 0.0 | 0.82 | 0.86 | ENVB | ||
| 0.0 | 0.95 | 0.0 | 0.9 | 0.86 | HEPA | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Elevation Stock performing well and Elevation Oncology Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Elevation Oncology's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CWBR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| OCEA | 7.12 | (3.00) | 0.00 | (1.94) | 0.00 | 15.38 | 51.00 | |||
| AVRO | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| ZURA | 4.61 | (0.40) | 0.00 | (0.23) | 0.00 | 9.79 | 29.06 | |||
| ENVB | 7.01 | (0.69) | 0.00 | (0.52) | 0.00 | 12.04 | 113.38 | |||
| HEPA | 9.87 | (3.91) | 0.00 | (5.38) | 0.00 | 16.37 | 90.05 |
Elevation Oncology Corporate Management
| Joseph Ferra | Chief Officer | Profile | |
| Valerie MD | Chief Officer | Profile | |
| RPh PharmD | President, Founder | Profile | |
| Ryan Bloomer | Senior Operations | Profile | |
| Biren Shah | Senior Development | Profile | |
| Brian Sullivan | VP Devel | Profile | |
| Candice Masse | Senior Relations | Profile |